-
EP0974363
European procedure
Extract from the Register of European Patents
EP About this file: EP0974363
| EP0974363 - REMEDIES FOR DRUG ADDICTION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.05.2006 Database last updated on 10.05.2025 | Most recent event Tooltip | 12.05.2006 | No opposition filed within time limit | published on 14.06.2006 [2006/24] | Applicant(s) | For all designated states TORAY INDUSTRIES, INC. 2-1, Nihonbashi Muromachi 2-chome, Chuo-ku Tokyo 103-8666 / JP | [N/P] |
| Former [2005/25] | For all designated states TORAY INDUSTRIES, INC. 2-1, Nihonbashi Muromachi 2-chome, Chuo-ku Tokyo 103-8666 / JP | ||
| Former [2000/04] | For all designated states TORAY INDUSTRIES, INC. 2-1, Nihonbashi Muromachi 2-chome, Chuo-ku Tokyo 103-8666 / JP | Inventor(s) | 01 /
NAGASE, Hiroshi 2-10-4, Kajiwara Kamakura-shi, Kanagawa 247-0063 / JP | 02 /
ENDOH, Takashi 1586-4, Hagizono Chigasaki-shi, Kanagawa 253-0071 / JP | 03 /
SUZUKI, Tsutomu 5-4-23-40, Youkoudai, Isogo-ku Yokohama-shi, Kanagawa 235-0045 / JP | 04 /
KAWAMURA, Kuniaki I-1, 1-20-33, Tsunishi Kamakura-shi, Kanagawa 248-0034 / JP | 05 /
OSHIMA, Koji 1-7-3-212, Nagahama, Kanazawa-ku Yokohama-shi, Kanagawa 236-0011 / JP | 06 /
INADA, Hideaki Kamakurayamaryou 403, 3-20-1, Kamakurayama Kamakura-shi, Kanagawa 248-0031 / JP | [2000/04] | Representative(s) | Coleiro, Raymond, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | [N/P] |
| Former [2000/04] | Coleiro, Raymond, et al MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 98941687.0 | 02.09.1998 | [2000/04] | WO1998JP03937 | Priority number, date | JP19970237426 | 02.09.1997 Original published format: JP 23742697 | JP19970252047 | 17.09.1997 Original published format: JP 25204797 | [2005/05] |
| Former [2000/04] | JP19970037426 | 02.09.1997 | |
| JP19970252047 | 17.09.1997 | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9911289 | Date: | 11.03.1999 | Language: | EN | [1999/10] | Type: | A1 Application with search report | No.: | EP0974363 | Date: | 26.01.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.03.1999 takes the place of the publication of the European patent application. | [2000/04] | Type: | B1 Patent specification | No.: | EP0974363 | Date: | 22.06.2005 | Language: | EN | [2005/25] | Search report(s) | International search report - published on: | JP | 11.03.1999 | (Supplementary) European search report - dispatched on: | EP | 20.03.2003 | Classification | IPC: | A61K31/485, C07D489/02, // C07D489:00 | [2003/19] | CPC: |
A61K31/485 (EP,US);
A61P25/30 (EP);
A61P25/32 (EP);
A61P25/34 (EP);
A61P25/36 (EP);
C07D489/08 (EP,US)
|
| Former IPC [2000/04] | A61K45/00, A61K31/47, // C07D489:00 | Designated contracting states | DE, FR, GB, IT [2000/04] | Title | German: | HEILMITTEL FÜR DIE DROGENABHÄNGIGKEIT | [2000/04] | English: | REMEDIES FOR DRUG ADDICTION | [2000/04] | French: | REMEDES CONTRE LA TOXICOMANIE | [2000/04] | Entry into regional phase | 28.05.1999 | Translation filed | 28.05.1999 | National basic fee paid | 28.05.1999 | Search fee paid | 28.05.1999 | Designation fee(s) paid | 28.05.1999 | Examination fee paid | Examination procedure | 28.05.1999 | Examination requested [2000/04] | 28.08.2003 | Despatch of a communication from the examining division (Time limit: M06) | 04.03.2004 | Reply to a communication from the examining division | 18.05.2004 | Despatch of a communication from the examining division (Time limit: M04) | 10.09.2004 | Reply to a communication from the examining division | 17.12.2004 | Communication of intention to grant the patent | 12.04.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 20.04.2005 | Request for decision received: Application is deemed to be withdrawn | 22.04.2005 | Fee for grant paid | 22.04.2005 | Fee for publishing/printing paid | 27.04.2005 | Result of request for decision (Application is deemed to be withdrawn): Request granted | Opposition(s) | 23.03.2006 | No opposition filed within time limit [2006/24] | Fees paid | Renewal fee | 22.09.2000 | Renewal fee patent year 03 | 24.09.2001 | Renewal fee patent year 04 | 24.09.2002 | Renewal fee patent year 05 | 23.09.2003 | Renewal fee patent year 06 | 22.09.2004 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PY]WO9749422 (UNIV ROCKEFELLER [US], et al) [PY] 3,4,7,10,13 * page 2, line 29 - page 3, line 26 *; | [DY]EP0577847 (TORAY INDUSTRIES [JP]) [DY] 3,4,7,10,13 * page 3, line 18 - page 5, line 38 *; | [PY] - PAN Z Z, "mu-Opposing actions of the kappa-opioid receptor", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, (19980301), vol. 19, no. 3, ISSN 0165-6147, pages 94 - 98, XP004115911 [PY] 3,4,7,10,13 * paragraph "Concluding Remarks" * * paragraph "kappa and mu-receptors mediate opposite subjective effects" * DOI: http://dx.doi.org/10.1016/S0165-6147(98)01169-9 | [PY] - JONES R M ET AL, "KAPPA-OPIOID RECEPTORS: RECENT ADVANCES AND IMPLICATIONS FOR DRUG DESIGN", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, (1998), vol. 1, ISSN 1367-6733, pages 175 - 182, XP001013241 [PY] 3,4,7,10,13 * figure 2 * | [Y] - SHIPPENBERG T S ET AL, "SENSITIZATION TO THE BEHAVIORAL EFFECTS OF COCAINE: MODULATION BY DYNORPHIN AND KAPPA-OPIOID RECEPTOR AGONISTS", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, ELSEVIER, US, (1997), vol. 57, no. 3, ISSN 0091-3057, pages 449 - 455, XP002043591 [Y] 3,4,7,10,13 * paragraph "Conclusions" * DOI: http://dx.doi.org/10.1016/S0091-3057(96)00450-9 | [A] - MALIN D H ET AL, "NALOXONE PRECIPITATES NICOTINE ABSTINENCE SYNDROME IN THE RAT", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, (1993), vol. 112, no. 2/3, ISSN 0033-3158, pages 339 - 342, XP001106964 [A] 3,4 * the whole document * DOI: http://dx.doi.org/10.1007/BF02244930 | [A] - KARRAS A ET AL, "NALOXONE REDUCES CIGARETTE SMOKING", LIFE SCIENCES, PERGAMON PRESS, OXFORD, GB, (1980), vol. 27, no. 17, ISSN 0024-3205, pages 1541 - 1545, XP001106436 [A] 3,4 * the whole document * DOI: http://dx.doi.org/10.1016/0024-3205(80)90562-7 | [A] - BARBER A ET AL, "NOVEL DEVELOPMENTS WITH SELECTIVE, NON-PEPTIDIC KAPPA-OPIOID RECEPTOR AGONISTS", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, (1997), vol. 6, no. 10, ISSN 1354-3784, pages 1351 - 1367, XP002071399 [A] 3,4,7,10,13 * page 1352, right hand column, 3rd paragraph *;; figure 3 * DOI: http://dx.doi.org/10.1517/13543784.6.10.1351 | [T] - TERENIUS L, "Rational treatment of addiction", CURRENT OPINION IN CHEMICAL BIOLOGY, CURRENT BIOLOGY LTD, LONDON, GB, (1998), vol. 2, no. 4, ISSN 1367-5931, pages 541 - 547, XP002956957 [T] 3,4,7,10,13 * the whole document * DOI: http://dx.doi.org/10.1016/S1367-5931(98)80132-4 | International search | [Y]WO9315081 (TORAY INDUSTRIES [JP]) | [X] - KUZUMIN ALEXANDER V. et al., "kappa-Opioid Receptor Agonist U50, 488H Modulates Cocaine and Morphine Self-Administration in Drug-Naive Rats and Mice", EUROPEAN JOURNAL OF PHARMACOLOGY, March 1997, Vol. 321, No. 3, pp. 265-271. | [X] - SHIPPENBERG T.S. et al., "kappa-Opioid Receptor Agonist Prevent Sensitization to the Conditioned Rewarding Effects of Cocaine", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, Vol. 276, No. 2, pp. 545-554. | [X] - MAISONNEUVE I.M. et al., "U50, 488, a kappa Opioid Receptor Agonist, Attenuates Cocaine-Induced Increases in Extracellular Dopamine in the Nucleus Accumbens of Rats", NEUROSCIENCE LETTERS, 1994, Vol. 181, No. 1-2, pp. 57-60. | [X] - HEIDBREDER Ch.A. et al., "The kappa-Opioid Receptor Agonist U-69593 Attenuates Cocaine-induced Behavioral Sensitization in the Rat", BRAIN RESEARCH, 1993, Vol. 616, No. 1-2, pp. 335-8. | [X] - TSUTOMU SUZUKI et al., "Opioid Receptor Type and Dependency (in Japanese)", FOLIA PHARMACOLOGICA JAPONICA, April 1997, Vol. 109, No. 4, pages 165-173. | [X] - FUNADA M. et al., "Blockade of Morphine Reward Through the Activation of kappa-Opioid Receptors in Mice", NEUROPHARMACOLOGY, 1993, Vol. 32, No. 12, pp. 1315-1323. | [X] - TSUTOMU SUZUKI et al., "Mechanism of Development of Drug Dependency (in Japanese)", MOLECULAR MEDICINE, 1995, Vol. 32, No. 2, pp. 140-145. | [Y] - DI CHIARA CAETANO et al., "Drugs Abused by Humans Preferentially Increase Synaptic Dopamine Concentrations in the Mesolimbic System of Freely Moving Rats", PROC. NATL. ACAD. SCI. USA, 1988, Vol. 85, No. 12, pp. 5274-5278. |